A phthalimide derivative that acts as a phosphodiesterase inhibitor (PDE-4 inhibitor), Apremilast is used for medium to severe chornic plaque psoriasis and psoriasis arthritis. It was approved for use in the US in 2014 and the EU in 2015.

Formula: C22H24N2O7S

Molecular weight: 460.00 g/mol

Molecular size: Small

Controlled Substance: No

Precursor: No

Indications: Immunosuppressants drugs

Status: In Development

Axano Pharmaceuticals Ltd
contact us now